Marco Siano
Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort study.
Schuler A, Huser J, Schmid S, Schär S, Scherz A, Gautschi O, Mauti L, von Briel T, Waibel C, Wannesson L, Pankovics J, Mark M, Rothschild S, Addeo A, Janthur W, Siano M, Boos L, Britschgi C, Früh M. Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort study. Lung Cancer 2023; 187:107427.
22.11.2023Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort study.
22.11.2023Lung Cancer 2023; 187:107427
Schuler Alexandra, Huser J, Schmid Sebastian M, Schär Sämi, Scherz Amina, Gautschi Oliver Pascal, Mauti Laetitia A, von Briel Thomas, Waibel Christine, Wannesson Luciano, Pankovics J, Mark Michael Thomas, Rothschild Sacha I, Addeo Alfredo, Janthur W, Siano Marco, Boos L, Britschgi Christian, Früh Martin
First-line treatment of NRAS-mutated metastatic melanoma with a MEK inhibitor
Bickel A, Diem S, Flatz L, Stinn B, Siano M. First-line treatment of NRAS-mutated metastatic melanoma with a MEK inhibitor. J Cancer Res Ther 2021; 17:276-278.
01.01.2021First-line treatment of NRAS-mutated metastatic melanoma with a MEK inhibitor
01.01.2021J Cancer Res Ther 2021; 17:276-278
Bickel Angelika, Diem Stefan, Flatz Lukas, Stinn Björn, Siano Marco
Radiation dosimetry of 18F-AzaFol: A first inhuman use of a folate receptor PET tracer
Müller J, Früh M, Siano M. Radiation dosimetry of 18F-AzaFol: A first inhuman use of a folate receptor PET tracer. EJNMMI Research 2020; 10
08.04.2020Radiation dosimetry of 18F-AzaFol: A first inhuman use of a folate receptor PET tracer
08.04.2020EJNMMI Research 2020; 10
Müller Joachim, Früh Martin, Siano Marco
Radiation dosimetry of F-AzaFol: A first in-human use of a folate receptor PET tracer
Gnesin S, Prior J, Treyer V, Kaufmann P, Ametamey S, Schibli R, Müller C, Choschzick M, Früh M, Siano M, Meisel A, Burger I, Müller J, Schaefer N. Radiation dosimetry of F-AzaFol: A first in-human use of a folate receptor PET tracer. EJNMMI Res 2020; 10:32.
08.04.2020Radiation dosimetry of F-AzaFol: A first in-human use of a folate receptor PET tracer
08.04.2020EJNMMI Res 2020; 10:32
Gnesin Silvano, Prior John O, Treyer Valerie, Kaufmann Philipp A, Ametamey Simon M, Schibli Roger, Müller Cristina, Choschzick Matthias, Früh Martin, Siano Marco, Meisel Alexander, Burger Irene A, Müller Joachim, Schaefer Niklaus
A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 4 (Biomarkers)
Broglie M, Negri S, Rothschild S, Giger R, Beffa L, Ballerini G, Huber G, Zwahlen D, Simon C, Putora P, Siano M, Henke G, Dulguerov P, Elicin O. A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 4 (Biomarkers). Front Oncol 2019; 9:1128.
24.10.2019A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 4 (Biomarkers)
24.10.2019Front Oncol 2019; 9:1128
Broglie Martina A, Negri Sandro V, Rothschild Sacha, Giger Roland, Beffa Lorenza, Ballerini Giorgio, Huber Gerhard, Zwahlen Daniel, Simon Christian, Putora Paul Martin, Siano Marco, Henke Guido, Dulguerov Pavel, Elicin Olgun
A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 3 (Medical Oncology)
Siano M, Negri S, Rothschild S, Giger R, Beffa L, Ballerini G, Huber G, Zwahlen D, Simon C, Putora P, Henke G, Broglie M, Dulguerov P, Elicin O. A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 3 (Medical Oncology). Front Oncol 2019; 9:1127.
24.10.2019A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 3 (Medical Oncology)
24.10.2019Front Oncol 2019; 9:1127
Siano Marco, Negri Sandro V, Rothschild Sacha, Giger Roland, Beffa Lorenza, Ballerini Giorgio, Huber Gerhard, Zwahlen Daniel, Simon Christian, Putora Paul Martin, Henke Guido, Broglie Martina A, Dulguerov Pavel, Elicin Olgun
A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 2 (Radiation Oncology)
Elicin O, Dulguerov P, Negri S, Rothschild S, Giger R, Beffa L, Ballerini G, Huber G, Zwahlen D, Simon C, Broglie M, Siano M, Putora P, Henke G. A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 2 (Radiation Oncology). Front Oncol 2019; 9:1126.
24.10.2019A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 2 (Radiation Oncology)
24.10.2019Front Oncol 2019; 9:1126
Elicin Olgun, Dulguerov Pavel, Negri Sandro V, Rothschild Sacha, Giger Roland, Beffa Lorenza, Ballerini Giorgio, Huber Gerhard, Zwahlen Daniel, Simon Christian, Broglie Martina A, Siano Marco, Putora Paul Martin, Henke Guido
A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 1 (Head and Neck Surgery)
den Hollander J, Negri S, Rothschild S, Giger R, Beffa L, Ballerini G, Huber G, Zwahlen D, Simon C, Putora P, Siano M, Henke G, Broglie M, Elicin O. A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 1 (Head and Neck Surgery). Front Oncol 2019; 9:1125.
24.10.2019A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 1 (Head and Neck Surgery)
24.10.2019Front Oncol 2019; 9:1125
den Hollander Jürgen, Negri Sandro V, Rothschild Sacha, Giger Roland, Beffa Lorenza, Ballerini Giorgio, Huber Gerhard, Zwahlen Daniel, Simon Christian, Putora Paul Martin, Siano Marco, Henke Guido, Broglie Martina A, Elicin Olgun
Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients
Fässler M, Jörger M, Recher M, Risch L, Güsewell S, Risch M, Speiser D, Ludewig B, Levesque M, Dummer R, Siano M, Krolik M, Diem S, Mangana J, Hasan Ali O, Berner F, Bomze D, Ring S, Niederer R, Gil Cruz C, Pérez Shibayama C, Flatz L. Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients. J Immunother Cancer 2019; 7:50.
20.02.2019Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients
20.02.2019J Immunother Cancer 2019; 7:50
Fässler Mirjam, Jörger Markus, Recher Mike, Risch Lorenz, Güsewell Sabine, Risch Martin, Speiser Daniel E, Ludewig Burkhard, Levesque Mitchell P, Dummer Reinhard, Siano Marco, Krolik Michal, Diem Stefan, Mangana Joanna, Hasan Ali Omar, Berner Fiamma, Bomze David, Ring Sandra, Niederer Rebekka, Gil Cruz Cristina, Pérez Shibayama Christian Ivan, Flatz Lukas
Time to systemic treatment and prognosis in patients with recurrent and metastatic head and neck squamous cell cancer
Siano M, Espeli V, Jörger M. Time to systemic treatment and prognosis in patients with recurrent and metastatic head and neck squamous cell cancer. Tumori 2018:300891618811276.
26.11.2018Time to systemic treatment and prognosis in patients with recurrent and metastatic head and neck squamous cell cancer
26.11.2018Tumori 2018:300891618811276
Siano Marco, Espeli Vittoria, Jörger Markus
Risk score for non-small cell lung cancer patients starting checkpoint inhibitor treatment
Diem S, Früh M, Güsewell S, Schmid S, Ackermann C, Roux G, Berner F, Niederer R, Siano M, Ali O, Fässler M, Flatz L. Risk score for non-small cell lung cancer patients starting checkpoint inhibitor treatment. Cancer Manag Res 2018; 10:5537-5544.
08.11.2018Risk score for non-small cell lung cancer patients starting checkpoint inhibitor treatment
08.11.2018Cancer Manag Res 2018; 10:5537-5544
Diem Stefan, Früh Martin, Güsewell Sabine, Schmid Sabine, Ackermann Christoph Jakob, Roux Guillaume-Alexandre, Berner Fiamma, Niederer Rebekka, Siano Marco, Ali Omar Hasan, Fässler Mirjam, Flatz Lukas
Cost-effectiveness of nivolumab in the treatment of head and neck cancer
Hirschmann A, Lupatsch J, Schwenkglenks M, Panje C, Matter-Walstra K, Espeli V, Dedes K, Siano M, Swiss Group of Clinical Cancer Research (SAKK). Cost-effectiveness of nivolumab in the treatment of head and neck cancer. Oral Oncol 2018; 87:104-110.
30.10.2018Cost-effectiveness of nivolumab in the treatment of head and neck cancer
30.10.2018Oral Oncol 2018; 87:104-110
Hirschmann A, Lupatsch J E, Schwenkglenks M, Panje Cédric, Matter-Walstra K, Espeli V, Dedes K J, Siano Marco, Swiss Group of Clinical Cancer Research (SAKK)
Prolonged Versus Short-Duration Use of Nasogastric Tubes in Patients with Head and Neck Cancer During Radiotherapy Alone or Combined Chemoradiotherapy
Espeli V, Vergotte S, Dietrich P, Pichard C, Siano M. Prolonged Versus Short-Duration Use of Nasogastric Tubes in Patients with Head and Neck Cancer During Radiotherapy Alone or Combined Chemoradiotherapy. Nutr Cancer 2018:1-6.
01.10.2018Prolonged Versus Short-Duration Use of Nasogastric Tubes in Patients with Head and Neck Cancer During Radiotherapy Alone or Combined Chemoradiotherapy
01.10.2018Nutr Cancer 2018:1-6
Espeli Vittoria, Vergotte Stephanie, Dietrich Pierre-Yves, Pichard Claude, Siano Marco
A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC)
Panje C, Lupatsch J, Plasswilm L, Aebersold D, Siano M, Gautschi O, Schwenkglenks M, Matter-Walstra K, Dedes K, Swiss Group for Clinical Cancer Research (SAKK). A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC). Radiother Oncol 2018; 129:257-263.
10.08.2018A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC)
10.08.2018Radiother Oncol 2018; 129:257-263
Panje Cédric, Lupatsch Judith E, Plasswilm Ludwig, Aebersold Daniel M, Siano Marco, Gautschi Oliver, Schwenkglenks Matthias, Matter-Walstra Klazien, Dedes Konstantin J, Swiss Group for Clinical Cancer Research (SAKK)
Percutaneous Endoscopic Gastrostomy Tube Is a Negative Prognostic Factor for Recurrent/Metastatic Head and Neck Cancer
Siano M, Jarisch N, Jörger M, Espeli V. Percutaneous Endoscopic Gastrostomy Tube Is a Negative Prognostic Factor for Recurrent/Metastatic Head and Neck Cancer. Anticancer Res 2018; 38:3725-3729.
01.06.2018Percutaneous Endoscopic Gastrostomy Tube Is a Negative Prognostic Factor for Recurrent/Metastatic Head and Neck Cancer
01.06.2018Anticancer Res 2018; 38:3725-3729
Siano Marco, Jarisch Nadine, Jörger Markus, Espeli Vittoria
Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial
Siano M, Espeli V, Mach N, Bossi P, Licitra L, Ghielmini M, Frattini M, Canevari S, De Cecco L. Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial. Oral Oncol 2018; 82:144-151.
28.05.2018Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial
28.05.2018Oral Oncol 2018; 82:144-151
Siano Marco, Espeli Vittoria, Mach Nicolas, Bossi Paolo, Licitra Lisa, Ghielmini Michele, Frattini Milo, Canevari Silvana, De Cecco Loris
Anti-PD-1 Therapy Leads to Near-Complete Remission in a Patient with Metastatic Basal Cell Carcinoma
Fischer S, Ali O, Jochum W, Kluckert J, Flatz L, Siano M. Anti-PD-1 Therapy Leads to Near-Complete Remission in a Patient with Metastatic Basal Cell Carcinoma. Oncol Res Treat 2018; 41:391-394.
03.05.2018Anti-PD-1 Therapy Leads to Near-Complete Remission in a Patient with Metastatic Basal Cell Carcinoma
03.05.2018Oncol Res Treat 2018; 41:391-394
Fischer Stefanie, Ali Omar H, Jochum Wolfram, Kluckert Jörg-Thomas, Flatz Lukas, Siano Marco
Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program
Balmelli C, Stenner F, Pless M, Weidner S, Zimmermann S, Güthner C, Cristina V, Cathomas R, Feuerlein K, Siano M, Railic N, Rothschild S. Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program. J Cancer 2018; 9:250-255.
01.01.2018Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program
01.01.2018J Cancer 2018; 9:250-255
Balmelli Catharina, Stenner Frank, Pless Miklos, Weidner Sabine, Zimmermann Stefan, Güthner Christiane, Cristina Valerie, Cathomas Richard, Feuerlein Kristin, Siano Marco, Railic Nikola, Rothschild Sacha I
Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?
Bossi P, Licitra L, Canevari S, Locati L, Pilotti S, Perrone F, Marchesi E, Paoli A, Tonella L, Giannoccaro M, Sponghini A, Cossu Rocca M, Bergamini C, Siano M, De Cecco L. Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?. Dis Markers 2017; 2017:6870614.
12.11.2017Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?
12.11.2017Dis Markers 2017; 2017:6870614
Bossi Paolo, Licitra Lisa, Canevari Silvana, Locati Laura D, Pilotti Silvana, Perrone Federica, Marchesi Edoardo, Paoli Alessandro, Tonella Luca, Giannoccaro Marco, Sponghini Andrea P, Cossu Rocca Maria, Bergamini Cristiana, Siano Marco, De Cecco Loris
Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer
Siano M, Frattini M, Ghielmini M, Corradino I, Freguia S, Früh M, Mach N, Martin V, Molinari F, Espeli V. Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer. Oncologist 2017
07.06.2017Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer
07.06.2017Oncologist 2017
Siano Marco, Frattini Milo, Ghielmini Michele, Corradino Irene, Freguia Stefania, Früh Martin, Mach Nicolas, Martin Vittoria, Molinari Francesca, Espeli Vittoria